We are live on
!
Find out more
MC
MRJ Capital Portfolio holdings
AUM
$173M
1-Year Est. Return
31.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.96%
1 Year Est. Return
+31.99%
3 Year Est. Return
+127.16%
5 Year Est. Return
+158.12%
10 Year Est. Return
–
AUM
$173M
AUM Growth
+$6.25M
(+3.7%)
Cap. Flow
-$1.58M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
37.21%
Holding
53
New
2
Increased
8
Reduced
31
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corteva
CTVA
|
+$2.02M |
| 2 |
Dow Inc
DOW
|
+$1.53M |
| 3 |
CVS Health
CVS
|
+$975K |
| 4 |
Constellation Brands
STZ
|
+$615K |
| 5 |
Walmart Inc
WMT
|
+$238K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.25M |
| 2 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$1.18M |
| 3 |
LyondellBasell Industries
LYB
|
+$563K |
| 4 |
SEE
Sealed Air
SEE
|
+$515K |
| 5 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$476K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.58% |
| 2 | Consumer Discretionary | 19.49% |
| 3 | Industrials | 11.85% |
| 4 | Technology | 11.07% |
| 5 | Materials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Axalta
AXTA
$6.92B
| $480K | 0.28% |
16,140
-13,400
| -45% | -$355K |
|
52
Travel + Leisure Co
TNL
$4.57B
| $259K | 0.15% |
5,900
| – | – |
|
|
53
AbbVie
ABBV
$450B
| – | – |
-15,462
| Closed | -$1.25M |
|
Similar funds
KM
TI
GC
REMS
NM
FAC
ACM
MSO
MRJ Capital's Q2 2019 Portfolio in Review
As of Q2 2019, MRJ Capital held 53 positions worth $173M, up 3.7% from $167M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
MRJ Capital's Q2 2019 filing shows 2 new, 8 increased, 31 reduced and 1 closed positions. Its largest new stake was Corteva: 75,242 shares worth $2.22M. The largest sale was AbbVie, an estimated $1.25M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.
- MRJ Capital's largest Q2 2019 buy was Corteva: 75,242 shares worth $2.22M.
- MRJ Capital added most to CVS Health in Q2 2019, an estimated $975K increase.
- MRJ Capital's biggest Q2 2019 reduction was Terminix Global Holdings, Inc., cutting an estimated $1.18M.
- MRJ Capital fully exited AbbVie in Q2 2019, selling an estimated $1.25M.
- MRJ Capital's ten largest holdings make up 37% of its $173M portfolio in Q2 2019.
- MRJ Capital opened 2 new positions and closed 1 in Q2 2019.
- MRJ Capital's portfolio value rose 3.7% quarter-over-quarter to $173M.
Based on MRJ Capital's 13F filing for Q2 2019, filed 14 Aug 2019.